Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6932-6938
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6932
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6932
Table 3 Adverse events n (%)
| First-line therapy | Moxifloxacin-containing triple therapy | |
| Diarrhea | 21 (7.9) | 25 (9.4) |
| Nausea/Vomiting | 14 (5.3) | 23 (8.7) |
| Abdominal pain | 14 (5.3) | 11 (4.2) |
| Taste distortion | 19 (7.2) | 4 (1.5) |
| Dizziness | 3 (1.1) | 1 (0.4) |
| Dyspepsia | 3 (1.1) | 5 (1.9) |
| Total | 76 (28.7) | 61 (23.1) |
-
Citation: Kang KK, Lee DH, Oh DH, Yoon H, Shin CM, Park YS, Kim N, Jung HC.
Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea. World J Gastroenterol 2014; 20(22): 6932-6938 - URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6932.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6932